← Все стартапы

Nephrogen
YCS20Curative gene therapies for kidney diseases
—
/ 100
О компании
Nephrogen is a biotech company developing curative gene therapies for kidney and pancreatic diseases. Kidney disease affects 1 in 7 Americans (~50 million people), has no cure, and accounts for nearly 10% of the Medicare budget.
Команда
1 чел.
Статус
Active